Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Allergy Therapeutics clinical trials
Part of ZQ Capital, which holds 60.5% as of 2026-03-12. Source
The registry lists 27 studies whose lead sponsor is Allergy Therapeutics. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 29, 2026.
Keep track of what changes. Save the Allergy Therapeutics studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Allergy Therapeutics.
- Allergy Therapeutics27 studiesSame company
Something wrong?
Focus areas
Conditions Allergy Therapeutics leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 27 of 27.
- GRASS (Grass MATA MPL Real-world Assessment Study)RecruitingNCT07412990
- An Exploratory Study of PQ Grass 27600 SUCompletedNCT04687059Phase 2/3
- Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic SubjectsActive, not recruitingNCT05476497Phase 1
- Tyrosine Allergoid Paediatric and Adult StudyActive, not recruitingNCT05186025
- Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass PollenCompletedNCT05540717Phase 3
- Effect of holoBLG on Cat Allergic PatientsCompletedNCT05455749Not applicable
- Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)WithdrawnNCT00109759Phase 1
- Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy VaccineCompletedNCT00133146Phase 2
- Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick TestCompletedNCT00258635Phase 2
- Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass PollenCompletedNCT00133159Phase 2
- Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree PollenCompletedNCT00118612Phase 2
- Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) LevelsCompletedNCT04389034
- Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™CompletedNCT02582073Phase 2
- Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic RhinitisTerminatedNCT00387478Phase 2
- A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPLCompletedNCT03931993Phase 1
- A Study of Tolerability and Safety of Two New Doses of Grass MATA MPLCompletedNCT02557633Phase 1
- Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed AllergyCompletedNCT00110786Phase 2
- Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen AllergenCompletedNCT00241410Phase 1
- Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree PollenCompletedNCT00113750Phase 2
- Efficacy and Safety/Tolerability of Grass MATA MPLCompletedNCT00414141Phase 3
- Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy VaccineCompletedNCT00118625Phase 2
- Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic RhinitisCompletedNCT00325338Phase 2
- Efficacy and Safety/Tolerability of Ragweed MATA MPLCompletedNCT00423787Phase 3
- Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick TestingCompletedNCT00107705Phase 1
- Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye PollenCompletedNCT00104377Phase 2
- Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick TestingCompletedNCT00116285Phase 1
- Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick TestingCompletedNCT00104390Phase 1